Jacob Chacko
President and CEO at Oric Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Oric Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Oric Pharmaceuticals Inc. June 18, 202699.6%
-
4D Molecular Therapeutics Inc. June 17, 202588.6%
-
Oric Pharmaceuticals Inc. June 14, 202398.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 16, 2025 | Oric Pharmaceuticals Inc. | Open-market sale | −33,374 | $9.06 | $302,368 |
| Dec 15, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +83,666 | — | — |
| Oct 6, 2025 | Oric Pharmaceuticals Inc. | Open-market sale | −37,461 | $12.32 | $461,520 |
| Oct 1, 2025 | Oric Pharmaceuticals Inc. | Open-market sale | −53,001 | $12.05 | $638,662 |
| Sep 30, 2025 | Oric Pharmaceuticals Inc. | Open-market sale | −34,538 | $12.01 | $414,801 |
| Sep 22, 2025 | Oric Pharmaceuticals Inc. | Open-market sale | −125,000 | $10.80 | $1,350,000 |
| Dec 16, 2024 | Oric Pharmaceuticals Inc. | Open-market sale | −24,660 | $8.28 | $204,185 |
| Dec 15, 2024 | Oric Pharmaceuticals Inc. | Option exercise | +67,000 | — | — |
| Mar 6, 2024 | Oric Pharmaceuticals Inc. | Open-market sale | −40,000 | $16.21 | $648,400 |
| Feb 7, 2024 | Oric Pharmaceuticals Inc. | Open-market sale | −26,042 | $12.30 | $320,317 |
| Feb 6, 2024 | Oric Pharmaceuticals Inc. | Open-market sale | −13,958 | $12.12 | $169,171 |
| Dec 15, 2023 | Oric Pharmaceuticals Inc. | Option exercise | +38,667 | — | — |
| Dec 15, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −14,539 | $8.58 | $124,745 |
| Jul 11, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −5,156 | $8.01 | $41,300 |
| Jul 10, 2023 | Oric Pharmaceuticals Inc. | Open-market sale | −10,508 | $8.01 | $84,169 |
Questions about Jacob Chacko
What boards is Jacob Chacko on?
Jacob Chacko sits on the boards of 4D Molecular Therapeutics Inc. and Oric Pharmaceuticals Inc.
What company is Jacob Chacko the CEO of?
Jacob Chacko is President and CEO of Oric Pharmaceuticals Inc.
How long has Jacob Chacko served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.